anti per2 antibody (Novus Biologicals)
Structured Review

Anti Per2 Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 15 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti per2 antibody/product/Novus Biologicals
Average 94 stars, based on 15 article reviews
Images
1) Product Images from "The circadian clock component PER2 deficiency aggravates airway epithelial remodeling through Wnt/β-catenin signaling pathway"
Article Title: The circadian clock component PER2 deficiency aggravates airway epithelial remodeling through Wnt/β-catenin signaling pathway
Journal: Respiratory Research
doi: 10.1186/s12931-026-03522-8
Figure Legend Snippet: Integrative bioinformatics and experimental validation identify circadian clock component PER2 as a key regulator in asthma. A Venn diagram of significant genes from GSE63142 and CRGs. B The Random Forest algorithm was selected 11 genes based on Mean Decrease Accuracy scores greater than 2.0. C The LASSO logistic regression algorithm determined 16 genes. D The PPI network analysis identified top 10 genes by the CytoHubba plugin. E Venn diagram of the overlapping hub genes between the Random Forest, LASSO algorithm and PPI network. F - G Association of PER2 and PER3 mRNA expression levels in bronchial epithelial cells between control ( n = 27), mild-moderate asthma (MMA) ( n = 72), and severe asthma (SA) ( n = 56) patients from GSE63142 . PER2 and PER3 mRNA expression levels have been logarithm base 2 (log2)-transformed. H - I Association of PER2 and PER3 mRNA expression levels in bronchial epithelial brushings between control ( n = 30), and patients with asthma ( n = 51) from GSE41861 . PER2 and PER3 mRNA expression levels have been log2-transformed. J - K Association of PER2 and PER3 mRNA expression levels in bronchial epithelial cells between control ( n = 20), mild-moderate asthma (MMA) ( n = 50), and severe asthma (SA) ( n = 38) patients from GSE43696 . PER2 and PER3 mRNA expression levels have been log2-transformed. L - O Correlation between PER2 mRNA expression in primary bronchial epithelial cells and FEV 1 (L), FEV 1 % predicted, FVC (L), IgE (IU/mL) was determined by Spearman analysis in patients with asthma from GSE201955 ( n = 79). P qPCR analysis of the expression of Per2 in lung tissues of mice ( n = 3). Q - R Western blot analysis the expression of PER2 in lung tissues of mice treated with OVA or PBS ( n = 3). S - T Representative Immunofluorescence staining of PER2 (Red) in the airway epithelium (SCGB1A1 Green) from asthmatic and control mice ( n = 3), original magnification 200 ×. Scale bars, 100 μm. Statistical significance was determined using the Kruskal-Wallis test followed by turkey’s comparison test for ( F , G , J , K ); Mann-Whitney U test for ( H , I ); spearman correlation for ( L - O ); and unpaired Student’s t-test for ( P , R , T ). CRG, circadian related genes; LASSO, least absolute shrinkage and selection operator; RF, random forest; PPI, protein-protein interaction; MMA, mild-moderate asthma; SA, severe asthma; FEV 1 , forced expiratory volume in 1 s; FVC, forced vital capacity; IgE, immunoglobulin E. ** P < 0.01, *** P < 0.001
Techniques Used: Biomarker Discovery, Expressing, Control, Transformation Assay, Western Blot, Immunofluorescence, Staining, Comparison, MANN-WHITNEY, Selection
Figure Legend Snippet: Per2 −/− mice aggravates OVA-induced AHR, airway inflammation, mucus production and fibrosis in experimental asthma. A Schematic illustrating the genetic approach used to knockout of Per2 mice. B Schematic overview of experimental design for the wildtype and Per2 −/− mouse model treated with OVA or PBS. C - E qPCR analysis and Western blot analysis the expression of PER2 in wildtype and Per2 −/− mouse lung tissues ( n = 3). F Non-invasive assessment of pulmonary function in mice after treatment with methacholine ( n = 5). G - K Total BALF cells, differential inflammatory cell counts of the lung sections were performed by Giemsa staining ( n = 5). L Representative images of H&E, PAS, and Masson staining of lung tissues from mice, original magnification 200 ×. Scale bars, 50 μm. M – O Inflammation scores based on H&E staining, PAS score based on PAS staining, and Masson’ Trichrome stain of lung tissues from mice ( n = 5). All data are expressed as mean ± SEM. Statistical significance was determined using unpaired Student’s t-test for (C, E); two-way repeated ANOVA followed by turkey’s comparison test for ( F ); and one-way ANOVA followed by Tukey’s post-hoc test for ( G - K , M - O ). AHR, airway hyperresponsiveness. * P < 0.05, ** P < 0.01, *** P < 0.001, ns, not significant
Techniques Used: Knock-Out, Western Blot, Expressing, Staining, Comparison
Figure Legend Snippet: PER2 deficiency aggravates airway remodeling via Wnt/β-catenin signaling pathway in vivo. A - E Representative Western blot images and statistical plots of protein quantitative analysis of N-cadherin, E-cadherin, MMP-9, and Vimentin in wildtype and Per2 −/− in lung tissues of mice ( n = 3). F - H qPCR analysis of the expression of Tgfb1 , Mmp2 and Muc5ac in lung tissues of mice ( n = 3). I - L Representative immunohistochemical images and quantitative estimation of E-cadherin, N-cadherin, and α-SMA in lung tissues of mice, original magnification 200 ×. Scale bars, 50 μm. All data are expressed as mean ± SEM. Statistical significance was determined using one-way ANOVA followed by Tukey’s post-hoc test for ( B - H , J - L ). * P < 0.05, ** P < 0.01, *** P < 0.001, ns, not significant
Techniques Used: In Vivo, Western Blot, Expressing, Immunohistochemical staining
Figure Legend Snippet: PER2 deficiency aggravates airway remodeling via Wnt signaling pathway in vivo. A - B A KEGG enrichment analysis in the lung tissues of WT-OVA compared to Per2 −/− -OVA. C - D Gene expression of TGF-β signaling pathway and EMT was assessed by Gene set enrichment analysis (GSEA). E - I Representative Western blotting images and statistical plots of protein quantitative analysis of β-catenin, GSK-3β, and p-GSK-3β in protein extracted from the lung tissues of mice ( n = 3). All data are expressed as mean ± SEM. Statistical significance was determined using one-way ANOVA followed by Tukey’s post-hoc test for (F-I). * P < 0.05, ** P < 0.01, *** P < 0.001, ns, not significant
Techniques Used: In Vivo, Gene Expression, Western Blot
Figure Legend Snippet: PER2 overexpression attenuates TGF-β1-induced EMT and migration in bronchial epithelial cells. A - B Representative Western blotting images and quantitative estimation of PER2 expression in TGF-β1-induced BEAS-2B cells for different doses was analyzed. C qPCR analysis of the PER2 expression in TGF-β1(10 ng/mL)-induced BEAS-2B cells. D - E Representative IF staining of PER2 in BEAS-2B cells stimulated with TGF-β1, original magnification 200 ×. Scale bars, 100 μm. F - H The expression of PER2 was studied by using qPCR and Western blot analysis. I - L Representative Western blotting images and quantitative estimation of N-cadherin, E-cadherin, α-SMA expression in TGF-β1-induced BEAS-2B cells. M - O qPCR analysis of the expression of MMP2 , SNAI1 and SNAI2 in BEAS-2B cells. P - Q Representative images and quantitative analysis of cell migration rates showing changes in BEAS-2B cell migration as assessed by scratch assays, original magnification 100 ×. Scale bars, 100 μm. R - S Representative images and quantitative analysis of cell migration rates showing changes in BEAS-2B cell migration as assessed by transwell assays, original magnification 100 ×. Scale bars, 100 μm. Statistical significance was determined using one-way ANOVA followed by Tukey’s post-hoc test for ( B , F , H , J - O , Q , S ), and unpaired Student’s t-test for ( C , E ). All data are expressed as mean ± SEM ( n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001, ns, not significant
Techniques Used: Over Expression, Migration, Western Blot, Expressing, Staining
Figure Legend Snippet: PER2 suppresses TGF-β1-induced EMT by inhibiting Wnt/β-catenin signaling activation. A A volcano plot showed Wnt signaling pathway and other circadian related genes (red, upregulated genes; blue, downregulated genes). B A The heatmap of differentially expressed genes. Results were based on 3 samples of RNA sequencing. C A KEGG enrichment analysis in the cultured BEAS-2B cells of PER2 OE + TGF-β1 compared to Vector + TGF-β1. D - H Representative Western blotting images and Statistical plots of protein quantitative analysis of β-catenin, GSK-3β, and p-GSK-3β in TGF-β1-induced BEAS-2B cells. I - L Representative Western blotting images and quantitative analysis of the expression levels of the N-cadherin, β-catenin, α-SMA following intervention with the β-catenin agonist SKL2001. M - O The effect of SKL2001 on the protein content of β-catenin was detected by Western blot in the cytosol and nuclear. P - Q The protein expression of β-catenin in nuclear and its quantification were identified by Immunofluorescence, original magnification 200 ×. Scale bars, 100 μm. All data are expressed as mean ± SEM ( n = 3). Statistical significance was determined using one-way ANOVA followed by Tukey’s post-hoc test for ( E - H , J - L , N , O , Q ). * P < 0.05, ** P < 0.01, *** P < 0.001, ns, not significant
Techniques Used: Activation Assay, RNA Sequencing, Cell Culture, Plasmid Preparation, Western Blot, Expressing, Immunofluorescence
Figure Legend Snippet: Immunofluorescence results of PER2 suppresses TGF-β1-induced EMT by inhibiting Wnt/β-catenin signaling activation. A - C The immunofluorescence analysis of N-cadherin, E-cadherin, and α-SMA expression after expression of PER2, original magnification 200 ×. Scale bars, 100 μm. D - F The relative fluorescence intensity of N-cadherin, E-cadherin, and α-SMA. All data are expressed as mean ± SEM ( n = 3). Statistical significance was determined using one-way ANOVA followed by Tukey’s post-hoc test for ( D - F ). * P < 0.05, ** P < 0.01, *** P < 0.001, ns, not significant
Techniques Used: Immunofluorescence, Activation Assay, Expressing, Fluorescence
Figure Legend Snippet: Melatonin exerts its protective effects against EMT of asthma by upregulating the PER2. A , Chemical Structure of melatonin is shown. B , Establishment of mouse models of OVA-induced asthma and melatonin treatment. C , The mRNA expression level of Per2 after treatment with melatonin in the lung tissues of mice was analyzed by using qPCR ( n = 3). D-E , Representative Western blotting images and quantitative estimation of PER2 after treatment with melatonin in wildtype and Per2 -/- mouse lung tissues ( n = 3). F , Non-invasive assessment of pulmonary function in mice after treatment with melatonin ( n = 5). G-K , Total BALF cells and differential inflammatory cell counts were performed by Giemsa staining ( n = 5). L-N , Representative lung sections and semiquantitative analysis of peri-airway inflammatory infiltration, and goblet cell hyperplasia in OVA-exposed mice after melatonin administration, original magnification×100. Scale bars, 50 μm. O-R , Representative Western blotting images and quantitative estimation of N-cadherin, E-cadherin, and Vimentin in the lung tissues of mice ( n = 3). All data are expressed as mean ± SEM. Statistical significance was determined using one-way ANOVA followed by Tukey’s post-hoc test for ( C , E , G - K , M , N , P - R ); and two-way repeated ANOVA followed by turkey’s comparison test for (F). * P < 0.05, ** P < 0.01, *** P < 0.001, ns, not significant
Techniques Used: Expressing, Western Blot, Staining, Comparison
